Neuromuscular electrical stimulation may help regulate blood glucose in type 2 diabetes

The review found that acute NMES interventions—single or short-term applications—consistently reduced postprandial (after-meal) glucose levels and short-term continuous glucose monitor readings. However, effects on fasting glucose and HbA1c (a marker of average blood glucose over 3 months) were less consistent across studies. Studies using stimulation of large lower-limb muscle groups and longer cumulative exposure times showed more favourable outcomes. NMES was generally well tolerated with high adherence rates and no major safety concerns reported. The researchers noted substantial methodological variation across the 10 studies prevented a formal meta-analysis, meaning the findings suggest potential but require larger, well-controlled trials with standardised protocols before firm conclusions can be drawn.

The variability in study design matters: most positive findings came from studies that either stimulated larger muscle groups (quadriceps, hamstrings, calf) rather than smaller muscles, or applied NMES sessions with greater cumulative duration and frequency. Mechanistically, electrical stimulation likely works by recruiting muscle fibres to contract and take up glucose from the blood without requiring voluntary effort—useful for people with mobility constraints, obesity, or exercise intolerance. One key limitation: studies ranged widely in stimulation parameters (frequency, intensity, duration, session length), making it hard to pinpoint the optimal protocol. The acute glucose benefit (seen immediately after NMES) is more robust than chronic effects, suggesting NMES might work best as an add-on to other interventions rather than a standalone treatment. The small sample sizes across most studies (many with fewer than 20 participants per arm) and lack of long-term follow-up (beyond weeks) mean the practical clinical impact remains uncertain.